Literature DB >> 3043178

Relationship among guanine nucleotide exchange, GTP hydrolysis, and transforming potential of mutated ras proteins.

L A Feig1, G M Cooper.   

Abstract

The effect of a series of mutations on the transforming potential of normal human rasH has been compared with their effects on GTPase and guanine nucleotide exchange rates of p21. The mutation Val-146 resulted in partial activation of transforming potential which could be attributed to a greater than 1,000-fold-increased rate of nucleotide exchange in the absence of an effect on GTPase. In contrast, the more modest enhancement of exchange rate (approximately 100-fold) which resulted from the mutation Met-14 did not affect biological activity. The partially activating mutation Thr-59 was found to result in both a 5-fold reduction in GTPase and a 10-fold increase in nucleotide exchange. However, the nontransforming mutant Ile-59 displayed a comparable decrease in GTPase without an effect on nucleotide exchange. The activating effect of the Thr-59 mutation may thus represent a combined effect of reduced GTPase and increased exchange. Similarly, the strongly activating mutation Leu-61 resulted in a fivefold increase in nucleotide exchange in addition to decreased GTPase, whereas weakly activating mutations at position 61 (Trp and Pro) resulted only in decreased GTPase without affecting nucleotide exchange rates. Finally, combining the two mutations Met-14 and Ile-59, which alone had no effect on biological activity, yielded a double mutant with a 20-fold increased transforming potential, demonstrating a synergistic effect of these two mutations. Overall, these results indicate that large increases in nucleotide exchange can activate ras transforming potential in the absence of decreased GTPase and that relatively modest increases in nucleotide exchange can act synergistically with decreased GTPase to contribute to ras activation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3043178      PMCID: PMC363447          DOI: 10.1128/mcb.8.6.2472-2478.1988

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  21 in total

1.  Biological and biochemical properties of human rasH genes mutated at codon 61.

Authors:  C J Der; T Finkel; G M Cooper
Journal:  Cell       Date:  1986-01-17       Impact factor: 41.582

2.  Intrinsic GTPase activity distinguishes normal and oncogenic ras p21 molecules.

Authors:  J B Gibbs; I S Sigal; M Poe; E M Scolnick
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

3.  Construction and applications of a highly transmissible murine retrovirus shuttle vector.

Authors:  C L Cepko; B E Roberts; R C Mulligan
Journal:  Cell       Date:  1984-07       Impact factor: 41.582

4.  Ha-ras proteins exhibit GTPase activity: point mutations that activate Ha-ras gene products result in decreased GTPase activity.

Authors:  V Manne; E Bekesi; H F Kung
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

5.  Ras p21 proteins with high or low GTPase activity can efficiently transform NIH/3T3 cells.

Authors:  J C Lacal; S K Srivastava; P S Anderson; S A Aaronson
Journal:  Cell       Date:  1986-02-28       Impact factor: 41.582

Review 6.  Structure/function analysis of ras using random mutagenesis coupled with functional screening assays.

Authors:  L A Feig; M Corbley; B T Pan; T M Roberts; G M Cooper
Journal:  Mol Endocrinol       Date:  1987-02

7.  Comparative biochemical properties of normal and activated human ras p21 protein.

Authors:  J P McGrath; D J Capon; D V Goeddel; A D Levinson
Journal:  Nature       Date:  1984 Aug 23-29       Impact factor: 49.962

8.  The product of ras is a GTPase and the T24 oncogenic mutant is deficient in this activity.

Authors:  R W Sweet; S Yokoyama; T Kamata; J R Feramisco; M Rosenberg; M Gross
Journal:  Nature       Date:  1984 Sep 20-26       Impact factor: 49.962

9.  Mutant ras-encoded proteins with altered nucleotide binding exert dominant biological effects.

Authors:  I S Sigal; J B Gibbs; J S D'Alonzo; G L Temeles; B S Wolanski; S H Socher; E M Scolnick
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

10.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

View more
  83 in total

1.  Dominant inhibitory Ras mutants selectively inhibit the activity of either cellular or oncogenic Ras.

Authors:  D W Stacey; L A Feig; J B Gibbs
Journal:  Mol Cell Biol       Date:  1991-08       Impact factor: 4.272

2.  Astrocytes phagocytose focal dystrophies from shortening myelin segments in the optic nerve of Xenopus laevis at metamorphosis.

Authors:  Elizabeth A Mills; Chung-ha O Davis; Eric A Bushong; Daniela Boassa; Keun-Young Kim; Mark H Ellisman; Nicholas Marsh-Armstrong
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-03       Impact factor: 11.205

3.  Signaling pathways that mediate nerve growth factor-induced increase in expression and release of calcitonin gene-related peptide from sensory neurons.

Authors:  K A Park; J C Fehrenbacher; E L Thompson; D B Duarte; C M Hingtgen; M R Vasko
Journal:  Neuroscience       Date:  2010-09-24       Impact factor: 3.590

4.  Interaction of ezrin with the novel guanine nucleotide exchange factor PLEKHG6 promotes RhoG-dependent apical cytoskeleton rearrangements in epithelial cells.

Authors:  Romina D'Angelo; Sandra Aresta; Anne Blangy; Laurence Del Maestro; Daniel Louvard; Monique Arpin
Journal:  Mol Biol Cell       Date:  2007-09-19       Impact factor: 4.138

5.  Arl2 and Arl3 regulate different microtubule-dependent processes.

Authors:  Chengjing Zhou; Leslie Cunningham; Adam I Marcus; Yawei Li; Richard A Kahn
Journal:  Mol Biol Cell       Date:  2006-03-08       Impact factor: 4.138

6.  ADP-ribosylation of p21ras and related proteins by Pseudomonas aeruginosa exoenzyme S.

Authors:  J Coburn; D M Gill
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

7.  Site-specific monoubiquitination activates Ras by impeding GTPase-activating protein function.

Authors:  G Aaron Hobbs; Harsha P Gunawardena; Rachael Baker; Sharon L Campbell
Journal:  Small GTPases       Date:  2013-09-12

8.  High-throughput sequencing screen reveals novel, transforming RAS mutations in myeloid leukemia patients.

Authors:  Jeffrey W Tyner; Heidi Erickson; Michael W N Deininger; Stephanie G Willis; Christopher A Eide; Ross L Levine; Michael C Heinrich; Norbert Gattermann; D Gary Gilliland; Brian J Druker; Marc M Loriaux
Journal:  Blood       Date:  2008-12-15       Impact factor: 22.113

9.  The Srp54 GTPase is essential for protein export in the fission yeast Schizosaccharomyces pombe.

Authors:  S M Althoff; S W Stevens; J A Wise
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

10.  Targeted deletion of RasGRP1 impairs skin tumorigenesis.

Authors:  Amrish Sharma; Lauren L Fonseca; Cynthia Rajani; Jodi K Yanagida; Yuka Endo; J Mark Cline; James C Stone; Junfang Ji; Joe W Ramos; Patricia S Lorenzo
Journal:  Carcinogenesis       Date:  2014-01-24       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.